Featured Article: Deficiency of G-protein coupled receptor 40, a lipid-activated receptor, heightens in vitro- and in vivo-induced murine osteoarthritis

作者: Laurent-Emmanuel Monfoulet , Claire Philippe , Sylvie Mercier , Véronique Coxam , Yohann Wittrant

DOI: 10.1177/1535370214565078

关键词:

摘要: Osteoarthritis (OA) is an age-related degenerative joint disease. To date, its management focused on symptoms (pain and inflammation). Studies suggest that fatty acids can reduce the expression of inflammatory catalytic mediators, improve in vivo function. Free acid receptors (FFARs) such as G-protein coupled receptor 40 (GPR40) are proposed attractive therapeutic targets to counteract inflammation cartilage degradation observed in OA. This study aims elucidate involvement GPR40 In this study, we used in vitro model OA, surgically induced OA by ligament transection partial meniscectomy wild-type deficient mice. phenotype was investigated histology genes expression. We demonstrate IL-1β-treated GPR40(-/-) chondrocytes secret more mediators (nitric oxide, interleukin-6, prostaglandin E2) active catabolic enzymes (metalloproteinase-2, -9 [MMP-2, MMP-9]), show decreased anabolism (glycoaminoglycan) compared GPR40(+/+) cells. accordance with these results, mice exhibit aggravated OA-induced characterized higher tidemark exposure, frequency osteophyte formation subchondral bone sclerosis. Altogether our results deficiency leads extended phenotype, providing evidence increasing activity, natural or synthetic ligands, could be a new strategy

参考文章(46)
Steve Rozen, Helen Skaletsky, Primer3 on the WWW for general users and for biologist programmers. Methods of Molecular Biology. ,vol. 132, pp. 365- 386 ,(2000) , 10.1385/1-59259-192-2:365
Karen Walker-Bone, Kassim Javaid, Nigel Arden, Cyrus Cooper, Medical management of osteoarthritis BMJ. ,vol. 321, pp. 936- 940 ,(2000) , 10.1136/BMJ.321.7266.936
Hyung Bin Park, Sang Cheol Seong, Ki Yong Byun, Jung Hwan Son, Young Bok Jung, Dong Chul Lee, Se Haeng Cho, Eun Kyoo Song, Clinical efficacy and safety of Lyprinol, a patented extract from New Zealand green-lipped mussel (Perna Canaliculus) in patients with osteoarthritis of the hip and knee: a multicenter 2-month clinical trial. European annals of allergy and clinical immunology. ,vol. 35, pp. 212- 216 ,(2003)
Julio C Fernandes, Jean-Pierre Pelletier, Johanne Martel-Pelletier, The role of cytokines in osteoarthritis pathophysiology. Biorheology. ,vol. 39, pp. 237- 246 ,(2002)
Richard F. Loeser, Steven R. Goldring, Carla R. Scanzello, Mary B. Goldring, Osteoarthritis: A disease of the joint as an organ Arthritis & Rheumatism. ,vol. 64, pp. 1697- 1707 ,(2012) , 10.1002/ART.34453
Reinout Stoop, Peter M. Van Der Kraan, Pieter Buma, Anthony P. Hollander, R. Clark Billinghurst, A. Robin Poole, Wim B. Van Den Berg, Type II collagen degradation in spontaneous osteoarthritis in C57Bl/6 and BALB/c mice. Arthritis & Rheumatism. ,vol. 42, pp. 2381- 2389 ,(1999) , 10.1002/1529-0131(199911)42:11<2381::AID-ANR17>3.0.CO;2-E
Richard F. Loeser, Age-related changes in the musculoskeletal system and the development of osteoarthritis. Clinics in Geriatric Medicine. ,vol. 26, pp. 371- 386 ,(2010) , 10.1016/J.CGER.2010.03.002
Cyrus Cooper, Shelagh Snow, Timothy E. McAlindon, Samantha Kellingray, Brenda Stuart, David Coggon, Paul A. Dieppe, Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis & Rheumatism. ,vol. 43, pp. 995- 1000 ,(2000) , 10.1002/1529-0131(200005)43:5<995::AID-ANR6>3.0.CO;2-1
S.S. Glasson, T.J. Blanchet, E.A. Morris, The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis and Cartilage. ,vol. 15, pp. 1061- 1069 ,(2007) , 10.1016/J.JOCA.2007.03.006